SEC Form 4Coverage since Jun 15, 2026
$AQST insider trading
Over the last 12 months, Aquestive Therapeutics insiders reported no purchases and 3 sales totaling $330K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $330K 3 events
- Events · 12m
- 3 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $AQST · 12Mvia TradingView
Top insiders · 12m
Barber DanielPresident and CEO2× · $204K
Krop Julie—1× · $125K
All insider trades
3 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Barber DanielPresident and CEO · O | ▼ Sale | 25,000 | $4.01 | $100K | -3.9% | plan · 2 tranches |
| Jun 23, 2026 | Krop JulieD | ▼ Sale | 25,000 | $5.02 | $125K | -100% | plan |
| Jun 15, 2026 | Barber DanielPresident and CEO · O | ▼ Sale | 25,000 | $4.16 | $104K | -3.8% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $AQST feed.